Disclosure profile

Who’s trading KD?

Kyndryl Holdings, Inc.

Every disclosed Congress and corporate-insider transaction in KD (Kyndryl Holdings, Inc.): 36 trades from 19 politicians and executives, each AI-scored. Updated as new filings land.

Create a free account to open trades, see the full AI breakdown, and get live alerts when KD is traded.

Create a free account →

FilerActionAmountFiledScore

Schroeter Martin JSEC Form 4—$594k2026-08-043

Keinan EllySEC Form 4—$467k2026-08-043

Chugh HarshSEC Form 4—$40k2026-08-043

Paulek Mark DSEC Form 4—$16k2026-08-043

HARRIS JOHN DSEC Form 4—$239k2026-08-034

Caruso Dominic JSEC Form 4—$240k2026-08-034

JACKSON SHIRLEY ASEC Form 4—$239k2026-08-034

Schreuder Jana RSEC Form 4—$239k2026-08-033

Merchant Rahul NSEC Form 4—$239k2026-08-034

Ungerleider Howard ISEC Form 4—$239k2026-08-034

Machuel DenisSEC Form 4—$240k2026-08-035

Kugel JaninaSEC Form 4—$239k2026-08-035

Hester Stephen A. M.SEC Form 4—$240k2026-08-033

Kyndryl Holdings, Inc. (KD)SEC 8-K——2026-07-316

Kyndryl Holdings, Inc. (KD)SEC 8-K——2026-07-065

Kyndryl Holdings, Inc. (KD) (CIK 0001867072)SEC Form 144Buy—2026-06-096

Keinan EllySEC Form 4——2026-06-053

Ringes MarkSEC Form 4——2026-06-053

Paulek Mark DSEC Form 4——2026-06-053

Kyndryl Holdings, Inc. (KD) (CIK 0001867072)SEC Form 144Buy—2026-06-054

Schroeter Martin JSEC Form 4——2026-06-053

Chugh HarshSEC Form 4——2026-06-053

Kyndryl Holdings, Inc. (KD) (CIK 0001867072)SEC Form 144Buy—2026-06-053

Schroeter Martin JSEC Form 4——2026-06-037

Chugh HarshSEC Form 4——2026-06-034

Ringes MarkSEC Form 4——2026-06-035

Doegar BhavnaSEC Form 4——2026-06-034

Paulek Mark DSEC Form 4——2026-06-035

Keinan EllySEC Form 4——2026-06-034

Schroeter Martin JSEC Form 4——2026-06-014

Keinan EllySEC Form 4——2026-06-015

Ringes MarkSEC Form 4——2026-06-015

Paulek Mark DSEC Form 4——2026-06-014

Chugh HarshSEC Form 4——2026-06-016

Hon. Dwight EvansHouse PTRSell$2242025-10-307

Hon. Steve CohenHouse PTRSell$1k2024-01-047

Public-record disclosures (SEC Form 4 & Congressional PTRs). Research tool, not investment advice.